FAU own research funding: EFI / IZKF / EAM ...
Start date : 01.08.2024
End date : 31.01.2027
A comprehensive molecular characterization of transcription factor dynamics in ccRCC evolution is a mandatory prerequisite for the development of personalized therapeutic interventions. Aim of this study is to define the components and interactions of oncogenic regulatory circuitries in ccRCC development with innovative NGS techniques. CRISPR/Cas-modified cell lines and patient-derived primary cells will be used to model early tumor stages and analyse epigenetic dysregulation in ccRCC evolution.